Preclinical studies with toremifene as an antitumor agent

This publication has 23 references indexed in Scilit:

• Inhibition of hormone-dependent and independent breast cancer cell growthin vivo andin vitro with the antiestrogen toremifene and recombinant human interferon-α2
  Breast Cancer Research and Treatment, 1990
• Metabolism of steroid-modifying anticancer agents
  Pharmacology & Therapeutics, 1988
• Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer
  New England Journal of Medicine, 1988
• Antitumor actions of toremifene in the 7,12-dimethylbenzanthracene (DMBA)-induced rat mammary tumor model
  European Journal of Cancer and Clinical Oncology, 1988
• Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer. Phase II study
  European Journal of Cancer and Clinical Oncology, 1988
• Quantitation of Toremifene and its Major Metabolites in Human Plasma by High-Performance Liquid Chromatography Following Fluorescent Activation
  Analytical Letters, 1987
• Estrogen and antiestrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes
  Cellular Immunology, 1987
• Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: Problems and potential for future clinical applications
  Breast Cancer Research and Treatment, 1983
• Natural Killer Cells: Characteristics and Regulation of Activity
  Immunological Reviews, 1979
• A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474
  British Journal of Cancer, 1971